IMUNON ($IMNN) posted quarterly earnings results on Thursday, February 27th. The company reported earnings of -$0.23 per share, beating estimates of -$0.37 by $0.14. The company also reported revenue of $0, equaling estimates of $0 by $0.
You can see Quiver Quantitative's $IMNN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
IMUNON Hedge Fund Activity
We have seen 8 institutional investors add shares of IMUNON stock to their portfolio, and 14 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SABBY MANAGEMENT, LLC removed 608,203 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $577,792
- ROYAL BANK OF CANADA added 40,095 shares (+2004750.0%) to their portfolio in Q4 2024, for an estimated $38,090
- COLONY GROUP, LLC removed 35,000 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $37,100
- RENAISSANCE TECHNOLOGIES LLC removed 30,050 shares (-47.2%) from their portfolio in Q4 2024, for an estimated $28,547
- NORTHERN TRUST CORP added 21,640 shares (+inf%) to their portfolio in Q4 2024, for an estimated $20,558
- XTX TOPCO LTD added 21,413 shares (+inf%) to their portfolio in Q4 2024, for an estimated $20,342
- CITADEL ADVISORS LLC removed 21,160 shares (-62.3%) from their portfolio in Q4 2024, for an estimated $20,102
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
